Pharmacogenetics: Opportunities and Challenges for Health Innovation
Hide / Show Abstract

Pharmacogenetics: Opportunities and Challenges for Health Innovation

Pharmacogenetics helps us understand the relationship between an individual’s genetic make-up and the way medicines work for each person. This book reviews the use of pharmacogenetics across all stages of the health innovation cycle from research through to uptake by doctors and patients. It focuses on how to optimise the use of pharmacogenetics to deliver effective innovations for public health, and design policies that enhance their economic and social benefits. The book argues for large-scale studies to validate the biomarkers that underpin pharmacogenetics and policies to share the cost and risk of using  pharmacogenetics to improve the use of existing  medicines. Governments and others need to align regulatory, reimbursement and other incentives and work  with industry to measure better the impacts of pharmacogenetics. Health systems need to take positive steps to adapt to the use of pharmacogenetics and ensure that health professionals receive adequate training.
Click to Access: 
    http://oecd.metastore.ingenta.com/content/9309081e.pdf
  • PDF
  • http://www.keepeek.com/Digital-Asset-Management/oecd/science-and-technology/pharmacogenetics-opportunities-and-challenges-for-health-innovation_9789264076808-en
  • READ
 
Chapter
 

Introduction to the Policy issues You do not have access to this content

English
Click to Access: 
    http://oecd.metastore.ingenta.com/content/9309081ec003.pdf
  • PDF
  • http://www.keepeek.com/Digital-Asset-Management/oecd/science-and-technology/pharmacogenetics-opportunities-and-challenges-for-health-innovation/introduction-to-the-policy-issues_9789264076808-3-en
  • READ
Author(s):
OECD

Hide / Show Abstract

This chapter serves as a general introduction to the issues raised by the potential adoption of pharmacogenetics in drug development and delivery, including its economic implications, which are examined in greater detail in the rest of the report.
 
Visit the OECD web site